Why Are Long-Term Steroids Avoided for Chronic Urticaria?
At a Glance
Long-term or repeated systemic steroids can temporarily calm chronic spontaneous urticaria but do not provide dependable long-term control and can cause bone loss, weight gain, high blood sugar, infections, and reduced natural steroid production. Guidelines favor antihistamines and steroid-sparing treatments.
In this answer
3 sections
Chronic Spontaneous Urticaria (CSU) is a condition where itchy, swollen hives appear unpredictably for at least six weeks without a consistent external trigger. When you are suffering from a severe flare-up, systemic (body-wide) corticosteroids like prednisone can temporarily reduce symptoms and provide rapid relief.
However, international treatment guidelines (such as those from the EAACI/GA²LEN/EuroGuiDerm/APAAACI) strongly advise against using systemic steroids for long-term maintenance [1]. While doctors may prescribe a short “rescue” burst during a severe exacerbation, prolonged or repeated courses do not provide sustainable control of the underlying disease and come with cumulative, serious risks [1] [2].
EMERGENCY WARNING
If your hives are accompanied by trouble breathing, difficulty swallowing, swelling of the throat or tongue, or fainting, seek emergency medical care immediately. These can be signs of a life-threatening allergic reaction (anaphylaxis) or dangerous angioedema. Use prescribed epinephrine if you have it. Prednisone is not a substitute for emergency treatment.
The Short-Term Relief vs. Long-Term Reality
Relying on repeated courses of steroids signals that your hives are not adequately controlled. Real-world observational data shows an association between systemic corticosteroid prescriptions in CSU patients and higher rates of adverse medical events and healthcare utilization [3]. While patients who receive steroids often have more severe disease to begin with, the risks of the medication itself become a major factor over time.
DO NOT STOP ABRUPTLY
If you have been taking systemic steroids continuously for a prolonged period, do not stop taking them abruptly or change your dose without medical supervision. Prolonged use can cause adrenal suppression (where your body stops making its own natural steroids). Your clinician must design a safe, individualized tapering plan to wean you off safely.
Severe Side Effects of Prolonged Use
The risk of side effects from systemic steroids generally increases with the dose, the duration of use, and the number of repeated courses you take [4].
- Bone Density Loss and Fractures: Glucocorticoid-induced bone loss can begin rapidly after starting treatment. Doses as low as 2.5 mg per day of prednisone (or equivalent) for more than three months are considered a threshold where doctors should assess you for fracture risk [5]. Prolonged exposure leads to a dose-dependent increase in fracture risk [6] [7].
- Weight Gain and Appearance Changes: Prolonged steroid exposure is heavily associated with excessive weight gain and Cushingoid features, which include a rounded face or fatty deposits on the back of the neck [8] [9] [10].
- Diabetes and Blood Sugar: Steroids interfere with how your body processes glucose. They can worsen your glucose tolerance within just a few weeks and are associated with a dose-dependent risk of developing diabetes [7] [11] [12].
- Immune Suppression and Infections: Steroids suppress your immune system, which increases your risk of opportunistic infections (infections, like shingles, that take advantage of a weakened immune system) [13]. While these risks are much higher with prolonged or high-dose treatment, even daily doses below 5 mg are not entirely risk-free [14].
Guideline-Recommended Alternatives
Because the risks of long-term steroids outweigh the benefits, guidelines outline a safer, stepwise approach to treating chronic hives (though specific medication approvals can vary by country) [1]:
- Optimized Antihistamines: Standard second-generation H1-antihistamines (like cetirizine or fexofenadine) are the first-line treatment. If standard doses fail, a clinician may direct you to increase the dose up to four times the approved amount [15] [16]. Do not self-escalate your dose. This must be clinician-directed, as some antihistamines can cause sedation, impair driving, or interact with other drugs.
- Biologic Therapies: If symptoms persist despite maximized antihistamines, guidelines suggest adding omalizumab, an anti-IgE biologic (a medication derived from living cells that targets specific immune pathways) [2] [15]. It requires medical administration and carries a rare risk of hypersensitivity reactions.
- Specialist-Monitored Immunosuppressants: For severe, resistant CSU, medications like cyclosporine may be used as a steroid-sparing option [17]. This is often an off-label use and requires close specialist monitoring for serious risks, including kidney dysfunction, high blood pressure, and drug interactions [17].
If your hives are not well-controlled without frequent prednisone, referral to a specialist—such as an allergist, immunologist, or dermatologist—is highly appropriate. Patients who see specialists are more likely to receive advanced, guideline-recommended biologic treatments and a clear long-term plan [16] [18].
Common questions in this guide
Why shouldn't I take prednisone long term for chronic hives?
Can prednisone be used during a severe chronic urticaria flare?
What health problems can long-term steroid use cause?
What treatments can be used instead of long-term steroids for chronic hives?
How should I stop prednisone after taking it for a long time?
When do hives require emergency medical care?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on chronic urticaria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many times have I used a steroid course for my hives recently, and does my total exposure justify screening for bone density or blood sugar changes?
- 2.Which specific daily antihistamine should I take, at what dose, and what side effects (like drowsiness) should I watch for?
- 3.What is our exact step-by-step plan if my current daily medication is not controlling my flare-ups?
- 4.Given my medical history, what specific monitoring would I need if we start advanced therapies like omalizumab or cyclosporine?
References
References (18)
- 1
Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
Hon KL, Li JTS, Leung AKC, Lee VWY
Expert opinion on pharmacotherapy 2021; (22(4)):497-509 doi:10.1080/14656566.2020.1829593.
PMID: 32990110 - 2
Chronic Spontaneous Urticaria: A Review.
Kolkhir P, Bonnekoh H, Metz M, Maurer M
JAMA 2024; (332(17)):1464-1477 doi:10.1001/jama.2024.15568.
PMID: 39325444 - 3
Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study.
Yosipovitch G, Patil D, Rodrigues J, et al.
Dermatology and therapy 2026; (16(8)):3905-3918 doi:10.1007/s13555-026-01776-0.
PMID: 42084779 - 4
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.
Scheire S, Lourijsen E, Blauwblomme M, et al.
Allergy 2026; (81(9)):3071-3106 doi:10.1111/all.70332.
PMID: 42011838 - 5
Management of glucocorticoid-induced osteoporosis.
Messina OD, Vidal LF, Wilman MV, et al.
Aging clinical and experimental research 2021; (33(4)):793-804 doi:10.1007/s40520-021-01823-0.
PMID: 33751462 - 6
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.
Compston JE
European journal of endocrinology 2023; (188(3)):R46-R55 doi:10.1093/ejendo/lvad029.
PMID: 36880157 - 7
Treatment patterns and impact of glucocorticoids on health outcomes in generalized myasthenia gravis: a retrospective observational study based on the Medical Data Vision database in Japan.
Teranishi H, Tsuda K, Harada D, et al.
Frontiers in neurology 2025; (16()):1625457 doi:10.3389/fneur.2025.1625457.
PMID: 41142144 - 8
Efficacy and safety of different oral prednisone tapering courses in adult anti-NMDAR encephalitis: A multicenter prospective cohort study.
Cai L, Li G, Abdulaziz AT, et al.
Epilepsia 2024; (65(11)):3199-3215 doi:10.1111/epi.18107.
PMID: 39324872 - 9
Corticosteroids for the treatment of Duchenne muscular dystrophy.
Matthews E, Brassington R, Kuntzer T, et al.
The Cochrane database of systematic reviews 2016; CD003725 doi:10.1002/14651858.CD003725.pub4.
PMID: 27149418 - 10
Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence.
Möhlmann JE, Ezzafzafi S, Lindemans CA, et al.
Clinical pharmacokinetics 2024; (63(9)):1251-1270 doi:10.1007/s40262-024-01419-7.
PMID: 39264575 - 11
MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
Radhakutty A, Burt MG
European journal of endocrinology 2018; (179(4)):R207-R218 doi:10.1530/EJE-18-0315.
PMID: 30299889 - 12
Clinical Impact of High-Dose Corticosteroids on Healthcare Resource Utilization and Steroid-Related Complications in Patients with Myasthenia Gravis in Japan.
Numajiri N, Yamamoto T, Waratani M, Takahashi MP
Neurology and therapy 2025; doi:10.1007/s40120-025-00850-7.
PMID: 41219665 - 13
Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort.
Yang SC, Lai YY, Huang MC, et al.
Lupus 2018; (27(11)):1819-1827 doi:10.1177/0961203318792352.
PMID: 30103646 - 14
Case Report: Simultaneous presence of Sarcoptes scabiei and fungal elements in scrapings from a patient with bullous pemphigoid.
Ye Y, Lv W, Chai L, et al.
Frontiers in medicine 2026; (13()):1773134 doi:10.3389/fmed.2026.1773134.
PMID: 41877790 - 15
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
Vestergaard C, Toubi E, Maurer M, et al.
European journal of dermatology : EJD 2017; (27(1)):10-19 doi:10.1684/ejd.2016.2905.
PMID: 27882879 - 16
[Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].
Costa C, Gonçalo M,
Acta medica portuguesa 2016; (29(11)):763-781 doi:10.20344/amp.8294.
PMID: 28229846 - 17
Management of Chronic Spontaneous Urticaria Made Practical: What Every Clinician Should Know.
Kocatürk E, Chu DK, Türk M, et al.
The journal of allergy and clinical immunology. In practice 2025; (13(9)):2252-2269 doi:10.1016/j.jaip.2025.07.021.
PMID: 40815254 - 18
Specialist care improves diagnosis and treatment for patients with chronic spontaneous urticaria: A real-world survey.
Mosnaim G, Hetherington J, Keal A, et al.
The journal of allergy and clinical immunology. Global 2026; (5(1)):100573 doi:10.1016/j.jacig.2025.100573.
PMID: 41210911
This page is for informational purposes only and is not medical advice. Do not stop or change systemic steroids without clinician guidance, and seek emergency care for breathing problems or throat or tongue swelling.